Renovaro Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $181 | $0 | $0 |
Gross Profit | 90 | -30 | ||
EBITDA | -7,104 | -52,191 | -50,880 | |
EBIT | -7,136 | -52,222 | -50,910 | |
Net Income | -7,252 | -15,731 | -17,024 | -58,990 |
Net Change In Cash | 0 | 181 | 0 | 0 |
Free Cash Flow | -4,576 | -2,437 | -2,639 | -2,639 |
Cash | 311 | 220 | 312 | 312 |
Basic Shares | 161,825 | 96,248 | 107,480 | 147,488 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -121 | -113 | -123 | -391 |
EBITDA | -79,516 | -19,483 | -22,702 | -23,278 |
EBIT | -79,638 | -19,596 | -22,826 | -23,401 |
Net Income | -80,650 | -39,684 | -113,433 | -26,723 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,041 | -11,804 | -15,737 | -20,659 |
Cash | 220 | 1,874 | 9,172 | 20,664 |
Basic Shares | 96,248 | 56,265 | 52,528 | 47,167 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.04 |
2024-09-30 | -$0.28 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.15 |
